Osirium Technologies : Contract win with major regional NHS Trust

RNS Reach Story
Go to market news section
Osirium Technologies PLC - OSI Contract win with major regional NHS Trust Released 07:00 20-Feb-2020

RNS Number : 5144D

Osirium Technologies PLC

20 February 2020

20 February 2020

RNS REACH

Osirium Technologies plc

('Osirium' or 'Group')

Contract win with major regional NHS Trust

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with one of the UK's largest regional NHS Trusts.

The new client has purchased a 36 month term license for 500 devices, withOsirium delivering its PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules.

The PxM platform has been selected in a public sector tender bid against competing bids from two other Privileged Access Management solution providers to minimise the risk of security breaches in a mixed Windows and Cisco environment. Drivers for the implementation include securing and controlling access to the infrastructure by the 3^rd party contractors, vendors and service providers on whom the Trust depends. The platform is also being used to enhance security by controlling and reducing the number of privileged accounts accessed by internal staff.

David Guyatt, Chief Executive Officer, commented: 'This brings another NHS Trust into our client roster and shows that Osirium is increasingly recognised as the PAM specialist best able to help these organisations address the security challenges they face. We see this as a further illustration of how NHS customers see us as strategic partners in strengthening the security of their IT operations.'

- Ends -

For further information:

Osirium Technologies plc	Tel: [phone]
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: [phone]
Fred Walsh / Neil Shah
Alma (Financial PR) Hilary Buchanan / Josh Royston / Kieran Breheny	Tel: [phone]

Notes to Editors:

Osirium Technologies plc (AIM: OSI) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Security solutions. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

Osirium has defined and delivered what the Directors view as the next generation Privileged Access Management solution. Osirium's award-winning Privileged Task Management module further strengthens Privileged Account Security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers. Building on Osirium's Privileged Task Management module, in May 2019 Osirium launched Privileged Process Automation, providing a highly-flexible platform for automating essential IT processes to set a new benchmark in IT Process Automation. This was followed by the launch of Privileged Endpoint Manager in December 2019, bringing the total portfolio to three complementary solutions.

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016. For further information please visit www.osirium.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRAKKCBPPBKDOBD

Close

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2014London Stock Exchange plc. All rights reserved

Contract win with major regional NHS Trust - RNS